Dova Pharmaceuticals, Inc.. (DOVA) NASDAQ
$28.04 - (-)
Market Cap: -
As of 11/11/19 04:00 PM EST. Market closed.
Dova Pharmaceuticals, Inc.. (DOVA)
NASDAQ
$28.04
- (-)
Market Cap: -
As of 11/11/19 04:00 PM EST. Market closed.
Add to Portfolio
Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was ... read more
COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO Compensation (Base)
$10,417
CEO Compensation (Total)
$4.38M
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO Compensation (Base)
$10,417
CEO Compensation (Total)
$4.38M
URL
Address
.
PRICE CHART FOR DOVA PHARMACEUTICALS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$5.62 - $28.54
Volume
0
Avg. Volume (30 days)
501,889
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
$5.62 - $28.54
Volume
0
Avg. Volume (30 days)
501,889
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR DOVA PHARMACEUTICALS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR DOVA PHARMACEUTICALS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Stalfort Sean | Director | Nov 12, 2019 | Option Exercise | $27.50 | 635,665 | 17,480,788 | 0 | Nov 12, 2019, 04:40 PM |
| Manning Paul B | Director | Nov 12, 2019 | Option Exercise | $27.50 | 1,783,226 | 49,038,715 | 0 | Nov 12, 2019, 04:38 PM |
| Manning Paul B | Director | Nov 12, 2019 | Option Exercise | $27.50 | 12,979,016 | 356,922,940 | 0 | Nov 12, 2019, 04:38 PM |
| ZACCARDELLI DAVID | President & CEO | Oct 01, 2019 | Sale | $27.90 | 5,275 | 147,172 | 76,647 | Oct 02, 2019, 04:21 PM |
| ALLEN LEE F MD PhD | Chief Medical Officer | Sep 30, 2019 | Sale | $28.00 | 978 | 27,384 | 9,635 | Oct 02, 2019, 04:21 PM |
| Hahn Mark W | Chief Financial Officer | Sep 30, 2019 | Sale | $28.00 | 775 | 21,700 | 9,024 | Oct 02, 2019, 04:20 PM |
| Hoitt Jason | Chief Commercial Officer | Sep 30, 2019 | Sale | $28.00 | 2,387 | 66,836 | 9,970 | Oct 02, 2019, 04:20 PM |
| Laliberte Kevin | Sr. VP, Product Development | Sep 30, 2019 | Sale | $28.00 | 3,696 | 103,488 | 5,357 | Oct 02, 2019, 04:20 PM |
| Laliberte Kevin | Sr. VP, Product Development | Sep 25, 2019 | Sale | $20.00 | 3,100 | 62,000 | 8,457 | Sep 27, 2019, 04:05 PM |
| Manning Paul B | Director | Aug 09, 2019 | Buy | $15.87 | 28,062 | 445,344 | 12,979,016 | Aug 12, 2019, 04:15 PM |
| Laliberte Kevin | Sr. VP, Product Development | Jul 31, 2019 | Sale | $15.97 | 1,389 | 22,182 | 11,557 | Aug 01, 2019, 04:31 PM |
| Hoitt Jason | Chief Commercial Officer | Jul 15, 2019 | Sale | $15.26 | 7,580 | 115,664 | 13,257 | Jul 16, 2019, 04:29 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jul 11, 2019 | Buy | $16.67 | 42,916 | 715,410 | 3,708,705 | Jul 11, 2019, 08:31 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jul 10, 2019 | Buy | $16.89 | 12,354 | 208,659 | 3,665,789 | Jul 11, 2019, 08:31 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jul 09, 2019 | Buy | $16.61 | 29,834 | 495,543 | 3,653,435 | Jul 11, 2019, 08:31 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jul 05, 2019 | Buy | $16.46 | 50,000 | 823,000 | 3,632,601 | Jul 09, 2019, 07:43 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jul 03, 2019 | Buy | $16.67 | 1,705 | 28,422 | 3,573,601 | Jul 03, 2019, 08:28 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jul 02, 2019 | Buy | $16.14 | 715 | 11,540 | 3,571,896 | Jul 03, 2019, 08:28 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jul 01, 2019 | Buy | $14.24 | 18,121 | 258,043 | 3,571,181 | Jul 03, 2019, 08:28 PM |
| ZACCARDELLI DAVID | President & CEO | Jul 02, 2019 | Sale | $15.94 | 10,450 | 166,608 | 86,473 | Jul 03, 2019, 04:24 PM |
| Hahn Mark W | Chief Financial Officer | Jul 01, 2019 | Sale | $14.17 | 1,545 | 21,893 | 9,799 | Jul 02, 2019, 04:59 PM |
| JEFFS ROGER | Director | Jul 01, 2019 | Sale | $14.17 | 1,308 | 18,534 | 66,993 | Jul 02, 2019, 04:58 PM |
| Laliberte Kevin | Sr. VP, Product Development | Jul 01, 2019 | Sale | $14.17 | 1,191 | 16,876 | 12,946 | Jul 02, 2019, 04:57 PM |
| ALLEN LEE F MD PhD | Chief Medical Officer | Jul 01, 2019 | Sale | $14.19 | 1,957 | 27,770 | 10,613 | Jul 02, 2019, 04:56 PM |
| Hoitt Jason | Chief Commercial Officer | Jun 28, 2019 | Sale | $13.81 | 2,387 | 32,963 | 20,087 | Jul 02, 2019, 04:55 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 28, 2019 | Buy | $14.17 | 100,000 | 1,417,085 | 3,553,060 | Jul 01, 2019, 07:23 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 27, 2019 | Buy | $13.10 | 327,209 | 4,286,124 | 3,453,060 | Jul 01, 2019, 07:23 PM |
| Goldman Steven M. | Director | Jun 26, 2019 | Option Exercise | $8.29 | 1,750 | 14,511 | 144,280 | Jun 27, 2019, 04:21 PM |
| Goldman Steven M. | Director | Jun 20, 2019 | Option Exercise | $8.29 | 1,750 | 14,509 | 142,530 | Jun 24, 2019, 04:54 PM |
| Goldman Steven M. | Director | May 13, 2019 | Option Exercise | $7.32 | 3,668 | 26,850 | 140,780 | Jun 03, 2019, 08:35 PM |
| Goldman Steven M. | Director | Jan 02, 2019 | Option Exercise | $7.32 | 4,583 | 33,548 | 137,112 | Jun 03, 2019, 08:35 PM |
| Hoitt Jason | Chief Commercial Officer | Apr 08, 2019 | Sale | $8.77 | 2,387 | 20,934 | 22,324 | Apr 10, 2019, 04:48 PM |
| Manning Paul B | Director | Mar 07, 2019 | Buy | $7.48 | 68,000 | 508,640 | 12,950,954 | Mar 08, 2019, 08:46 AM |
| JEFFS ROGER | Director | Dec 20, 2018 | Buy | $6.25 | 1,169 | 7,306 | 61,400 | Dec 21, 2018, 05:12 PM |
| JEFFS ROGER | Director | Dec 19, 2018 | Buy | $6.22 | 28,831 | 179,329 | 60,231 | Dec 21, 2018, 05:12 PM |
| ZACCARDELLI DAVID | President & CEO | Dec 20, 2018 | Buy | $6.07 | 10,000 | 60,700 | 92,372 | Dec 21, 2018, 05:11 PM |
| Manning Paul B | Director | Dec 21, 2018 | Buy | $6.48 | 128,500 | 832,050 | 12,882,954 | Dec 21, 2018, 05:09 PM |
| Stalfort Sean | Director | Dec 20, 2018 | Buy | $6.26 | 31,000 | 194,060 | 635,665 | Dec 21, 2018, 05:07 PM |
| Hahn Mark W | Chief Financial Officer | Dec 19, 2018 | Buy | $6.28 | 2,500 | 15,700 | 2,500 | Dec 21, 2018, 05:05 PM |
| Manning Paul B | Director | Dec 20, 2018 | Buy | $6.17 | 266,631 | 1,645,113 | 12,754,454 | Dec 20, 2018, 05:28 PM |
| Sapir Alex | President & CEO | Aug 14, 2018 | Buy | $22.83 | 21,700 | 495,411 | 21,700 | Aug 15, 2018, 04:27 PM |
| Goldman Steven M. | Director | Aug 13, 2018 | Option Exercise | $7.32 | 1,832 | 13,410 | 125,001 | Aug 15, 2018, 07:46 AM |
| Goldman Steven M. | Director | Jun 21, 2018 | Buy | $30.22 | 5,000 | 151,100 | 123,169 | Jun 25, 2018, 08:07 AM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 11, 2018 | Buy | $29.36 | 19,700 | 578,424 | 3,125,851 | Jun 13, 2018, 04:10 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 08, 2018 | Buy | $28.65 | 25,000 | 716,200 | 3,106,151 | Jun 12, 2018, 04:07 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 07, 2018 | Buy | $28.18 | 50,000 | 1,409,154 | 3,081,151 | Jun 11, 2018, 04:37 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 06, 2018 | Buy | $28.66 | 100,000 | 2,865,716 | 3,031,151 | Jun 08, 2018, 04:07 PM |
| Manning Paul B | Director | Jun 06, 2018 | Buy | $28.85 | 17,000 | 490,450 | 12,477,823 | Jun 08, 2018, 08:17 AM |
| Manning Paul B | Director | Jun 07, 2018 | Buy | $27.69 | 10,000 | 276,934 | 12,487,823 | Jun 08, 2018, 08:17 AM |
| Goldman Steven M. | Director | Jun 06, 2018 | Option Exercise | $7.32 | 11,000 | 80,520 | 118,169 | Jun 07, 2018, 08:53 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 05, 2018 | Buy | $25.99 | 100,000 | 2,598,622 | 2,931,151 | Jun 07, 2018, 04:29 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 04, 2018 | Buy | $25.07 | 10,000 | 250,700 | 2,831,151 | Jun 06, 2018, 04:24 PM |
| Goldman Steven M. | Director | Jun 05, 2018 | Buy | $26.41 | 15,000 | 396,150 | 107,169 | Jun 06, 2018, 08:04 AM |
| Manning Paul B | Director | Jun 04, 2018 | Buy | $24.45 | 20,000 | 489,014 | 12,360,823 | Jun 06, 2018, 08:03 AM |
| Manning Paul B | Director | Jun 05, 2018 | Buy | $26.51 | 100,000 | 2,651,188 | 12,460,823 | Jun 06, 2018, 08:03 AM |
| Sapir Alex | President & CEO | Dec 22, 2017 | Option Exercise | $3.73 | 26,809 | 99,998 | 46,909 | Dec 27, 2017, 04:32 PM |
| Manning Paul B | Director | Aug 16, 2017 | Buy | $25.12 | 5,000 | 125,578 | 125,870 | Aug 17, 2017, 07:01 PM |
| Manning Paul B | Director | Aug 15, 2017 | Buy | $21.62 | 20,870 | 451,289 | 120,870 | Aug 17, 2017, 07:01 PM |
| Goldman Steven M. | Director | Aug 15, 2017 | Buy | $22.23 | 20,169 | 448,382 | 92,169 | Aug 17, 2017, 07:00 PM |
| Goldman Steven M. | Director | Jul 05, 2017 | Buy | $19.64 | 5,000 | 98,200 | 5,000 | Aug 17, 2017, 06:58 PM |
| Manning Paul B | Director | Jul 05, 2017 | Buy | $17.00 | 100,000 | 1,700,000 | 100,000 | Jul 07, 2017, 06:50 AM |
| Manning Paul B | Director | Jul 05, 2017 | Buy | $17.00 | 50,000 | 850,000 | 1,783,226 | Jul 07, 2017, 06:50 AM |
| ALLEN LEE F MD PhD | Chief Medical Officer | Jul 05, 2017 | Buy | $17.00 | 3,500 | 59,500 | 3,500 | Jul 07, 2017, 06:48 AM |
| Laliberte Kevin | Sr. VP, Product Development | Jul 05, 2017 | Buy | $17.00 | 6,200 | 105,400 | 6,200 | Jul 07, 2017, 06:47 AM |
| JEFFS ROGER | Director | Jul 05, 2017 | Buy | $17.00 | 31,400 | 533,800 | 31,400 | Jul 07, 2017, 06:46 AM |
| Goldman Steven M. | Director | Jul 05, 2017 | Buy | $17.94 | 72,000 | 1,291,500 | 72,000 | Jul 07, 2017, 06:45 AM |
| Sapir Alex | President & CEO | Jul 05, 2017 | Buy | $17.00 | 20,100 | 341,700 | 20,100 | Jul 07, 2017, 06:44 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR DOVA PHARMACEUTICALS, INC.
LOADING...